Funding & Investment

New biotech Rinascera launches with a veteran team and a clinical-stage pipeline. Is its disciplined, asset-acquisition strategy the future for rare diseases?

CraniUS Therapeutics secures up to $4M in NIH funding for its NeuroPASS device, a refillable implant aiming to revolutionize glioblastoma and CNS treatment.

A federal AI investment is coming. But the real story isn’t the cheque—it’s the strategic alignment of ministers and the choice of venue. Here's what it signals.

With Japan facing a 'knowledge bomb' from a retiring workforce, Trupeer AI bets on a UiPath veteran to build the one thing enterprise AI is missing: context.

AIXAlpha promises to make volatile crypto markets accessible to all. But as automation replaces experience, are investors gaining an edge or just new risks?

Led by an Anker veteran, ETOE launches its premium Dolphin 2 projector. Can its RGB triple-laser tech and smart features disrupt the crowded market?

At BIO 2026, Fapon Group unveils a novel strategy combining T-cell engagers and in vivo CAR-T to target complex diseases. What does this mean for the future?

A small travel platform bets big on North America-India routes, promising deep discounts and a better experience. But can it deliver against industry giants?

Defiance ETFs launches Europe's first memory-focused fund as analysts predict prices could soar 130%, reshaping the entire global technology supply chain.

Arverne CEO Pierre Brossollet's move to increase his stake is more than a vote of confidence; it's a strategic key unlocking a €70M investment.

The biotech firm's revenue plummeted as losses soared. But behind the numbers is a calculated pivot to cancer therapy, fueled by a Nasdaq debut and new cash.

A new AI agent from a JetBrains spin-off aims to automate social media strategy, freeing creators to focus on their craft and build profitable businesses.

A new marketplace bridges the $250B creator economy and automated advertising, offering a vital new revenue stream for independent media and a new frontier for AI.

The gas shipping giant just secured $206 million for new vessels, but the real story isn't the money—it's the sophisticated financial tool they used.

As fusion startup Avalanche Energy hits solar-core temperatures, its new CFO hire signals a pivotal shift from pure science to serious commercial ambition.

As hotels struggle with staff shortages, Croux expands its AI-powered platform to seven cities, promising a 96% show-up rate by treating staffing as a prediction problem.

A PR firm launches a daily financial newsletter for the lower middle market, betting that speed and focus can win over dealmakers in a crowded, vital field.

A new grant from The Michael J. Fox Foundation highlights a radical approach to Parkinson's: targeting astrocytes to restore balance and halt neurodegeneration.

With its 10th acquisition and a fresh $40M, Connie Health is using its AI platform to rapidly scale and become a key partner in value-based care.